IRHYTHM TECHNOLOGIES INC (IRTC) Stock News
NASDAQ:IRTC - Nasdaq - US4500561067 - Common Stock - Currency: USD
IRTC Latest News, Press Relases and Analysis
iRhythm Technologies to Participate in Upcoming Investor Conferences
SAN FRANCISCO, May 21, 2025 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating...
iRhythm Technologies to Participate in Upcoming Investor Conferences
After 92% YTD Surge, Is Tempus AI a Buy on Trump's Executive Order?
President Donald Trump's new executive order aiming to cut U.S. drug prices could benefit Tempus AI.
Why iRhythm Technologies (IRTC) Is Among the Best Performing Healthcare Stocks to Buy Now
We recently published a list of 11 Best Performing Healthcare Stocks to Buy Now. In this article, we are going to take a look at where iRhythm Technologies, Inc. (NASDAQ:IRTC) stands against other best performing healthcare stocks to buy now. Trump’s Healthcare Executive Order Brings a Win On April 15, CNBC reported that President Trump’s […]
Your Rich BFF Vivian Tu: Why ‘Everyone Is Freaking Out’ About the Bond Market Amid Tariffs
As Your Rich BFF founder and CEO Vivian Tu explained in a TikTok video, savvy investors are avoiding the bond market, indicating there may be a deeper problem.
4 Reasons You Should Stand Pat on Walmart Stock Amid Tariffs and Inflation, According to Experts
Walmart's CEO told Trump his tariffs could affect global supply chains and "lead to empty shelves." Does that spell bad news for its business and stock?
How Much Would It Take To Earn $100 A Month From T. Rowe Price Group Stock
T. Rowe Price Group (NASDAQ:TROW) is a publicly owned investment manager, which provides its services to individuals, institutional investors, retirement plans, financial intermediaries, and institutions. The 52-week range of T. Rowe Price Group stock ...
Trump’s Tariffs: 7 Things To Do Now If You’re Worried About the Unpredictable Stock Markets
As tariff-driven price hikes rattle the stock market, it's easy to feel like your financial stability is also at risk, especially if your portfolio dips. However, market swings tied to global trade...
Wells Fargo Upgrades iRhythm Technologies Stock, Raises Price Target To $130: Retail’s Thrilled
The firm’s new target on iRhythm implies a 19.7% upside to Thursday’s closing price.
IRhythm Technologies (IRTC) Reports Q1 Loss, Tops Revenue Estimates
iRhythm Technologies (IRTC) delivered earnings and revenue surprises of -6.74% and 3.34%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Mentions: HIMS
iRhythmは、日本においてZio ECG記録・解析システムとしてZio®長期連続モニタリング サービスを開始し、AIを活用した不整脈検出の進化を推進します。
日本で「Zio ECG記録・解析システム」として商業的に導入されたiRhythm...
iRhythm Launches Zio® Long-Term Continuous Monitoring Service in Japan as the Zio® ECG Recording and Analysis System, Advancing AI-Powered Arrhythmia Detection
iRhythm brings AI-powered Zio® ECG Monitoring System to Japan, delivering 14-day continuous heart monitoring amid rising arrhythmia rates....
iRhythm Technologies Announces First Quarter 2025 Financial Results
SAN FRANCISCO, May 01, 2025 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care company focused on creating...
iRhythm Technologies Announces First Quarter 2025 Financial Results
iRhythm Technologies to Present at the Bank of America Securities 2025 Health Care Conference
SAN FRANCISCO, April 29, 2025 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating...
iRhythm Presents New Real-World Data on Ambulatory Cardiac Monitoring at HRS 2025 Reinforcing Clinical Superiority of Zio Long-Term Continuous Monitoring
Data show iRhythm Zio LTCM clinical superiority with higher diagnostic yield, fewer retests, and fewer CV events vs. all other LTCMs products...
The Zacks Analyst Blog Highlights Tempus AI, AstraZeneca, iRhythm Technologies and SOPHiA GENETICS
Tempus AI, AstraZeneca, iRhythm Technologies and SOPHiA GENETICS are included in this Analyst Blog.
Tempus AI Stock Sees 21% Gain in 3 Days: Is it a Buy After AZN Deal?
TEM stock rises for three successive days. Should you expect more upside ahead, or is it time to dump Tempus AI?
iRhythm Technologies to Report First Quarter 2025 Financial Results on May 1, 2025
iRhythm Technologies to Report First Quarter 2025 Financial Results on May 1, 2025...
iRhythm Technologies to Report First Quarter 2025 Financial Results on May 1, 2025
iRhythm Technologies Releases 2024 Corporate Sustainability Report That Demonstrates Ongoing Commitment to Culture of Quality and Sustainability
iRhythm Technologies Releases 2024 Corporate Sustainability Report That Demonstrates Ongoing Commitment to Culture of Quality and Sustainability...